Alembic Pharma under Pressure as USFDA Issues Form 483 to Gujarat Plant
Synopsis: Alembic Pharma share price fell over 4 percent in intraday trade on December 16 following reports that the US Food and…
Synopsis: Alembic Pharma share price fell over 4 percent in intraday trade on December 16 following reports that the US Food and…
Synopsis: UEFA is set to launch a video aimed at players featuring doctors explaining the benefits of vaccinations. Ceferin said the video…
Synopsis: The EMA’s human medicines committee has said it cannot approve Biogen and Eisai’s Alzheimer’s disease therapy Aduhelm, saying it was unconvinced…
Synopsis- India-made Covovax on Friday became the ninth Covid-19 vaccine to receive WHO’s emergency use listing approval, with manufacturer Serum Institute of…
Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…
Summary – The European Medicines Agency (EMA) has issued a list of about 100 regulatory science topics that need further research to close…
Synopsis- Under the extended contract, the dedicated R&D center, ‘Syngene Amgen Research and Development Center’ (SARC), will continue to conduct drug discovery…
Synopsis : – The administration of the vaccine in accordance with the official recommendation can effectively prevent invasive disease and pneumonia caused…
Synopsis- The provisional approval is for two doses of the paediatric Pfizer COVID-19 vaccine, given at least 21 days apart, the health…
Synopsis- The ZY19489 is a novel antimalarial compound active against all current clinical strains of malaria-causing microorganisms ‘P. falciparum’ and ‘P. vivax’,…